nifedipine has been researched along with 8,11,14-eicosatrienoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couture, R; Laneuville, O; Pace-Asciak, CR | 1 |
| Busse, R; Chataigneau, T; Fisslthaler, B; Fleming, I; Hinsch, N; Kiss, L; Popp, R | 1 |
| Busse, R; Fisslthaler, B; Fleming, I; Hammock, BD; Janssens, A; Morisseau, C; Nilius, B; Owsianik, G; Suzuki, M; Voets, T; Vriens, J | 1 |
3 other study(ies) available for nifedipine and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Aorta, Thoracic; Calcium; Drug Synergism; Glutathione; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Portal Vein; Rats; Rats, Inbred Strains; Stereoisomerism | 1992 |
Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Biological Factors; Bradykinin; Cells, Cultured; Coronary Vessels; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Nifedipine; Protein Kinase C; RNA; Swine; Vasodilation; Vasodilator Agents | 2000 |
Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Calcium; Cells, Cultured; Cytochrome P-450 Enzyme System; Endothelial Cells; Epoxide Hydrolases; Mice; Nifedipine; TRPV Cation Channels | 2005 |